CN101302218B - Preparation of Trandolapril diketone - Google Patents

Preparation of Trandolapril diketone Download PDF

Info

Publication number
CN101302218B
CN101302218B CN2007100404217A CN200710040421A CN101302218B CN 101302218 B CN101302218 B CN 101302218B CN 2007100404217 A CN2007100404217 A CN 2007100404217A CN 200710040421 A CN200710040421 A CN 200710040421A CN 101302218 B CN101302218 B CN 101302218B
Authority
CN
China
Prior art keywords
trandolapril
diketone
preparation
organic solvent
trolapril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007100404217A
Other languages
Chinese (zh)
Other versions
CN101302218A (en
Inventor
李建华
钟静芬
时惠麟
胡功允
周虎
金永君
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
Original Assignee
Shanghai Institute of Pharmaceutical Industry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry filed Critical Shanghai Institute of Pharmaceutical Industry
Priority to CN2007100404217A priority Critical patent/CN101302218B/en
Publication of CN101302218A publication Critical patent/CN101302218A/en
Application granted granted Critical
Publication of CN101302218B publication Critical patent/CN101302218B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Indole Compounds (AREA)

Abstract

The invention discloses a method for preparing Trandolapril diketone. The method comprises a step of using Trandolapril to react in a soluble organic solvent, wherein the reaction temperature is lower than or equal to the boiling point of the organic solvent, and then the Trandolapril diketone can be obtained. The method is simple and easy to operate and high in yield, and greatly reduces the three wastes.

Description

The preparation method of Trandolapril diketone
Technical field
The invention belongs to the pharmaceutical chemistry field, specifically, relate to the preparation method of Trandolapril diketone.
Background technology
Trolapril (Trandolapril) is by the exploitation of the Roussel Uclaf company of Germany (II), a kind of long lasting angiotensin-convertion enzyme inhibitor (ACEI) that the Sanofi-Aventis company of France produces, went on the market in France in 1993, be used for the treatment of hypertension, congestive heart failure and myocardial infarction.Its chemical being called (2S, 3aR, 7aS)-1-[(2S)-2-[[(1S)-and 1-(ethoxycarbonyl)-3-hydrocinnamyl] amino]-the 1-oxopropyl] octahydro-1H-Indoline-2-carboxylic acid.
Trandolapril diketone (I) is the impurity of Trolapril (II), and about requiring the amount of control Trandolapril diketone (I) to be no more than 0.5% in the record of Trolapril, the existence of Trandolapril diketone can influence the physiologically active of Trolapril in the European Pharmacopoeias in 2006.
Figure S07140421720070531D000011
For synthetic qualified Trolapril, need at first synthetic Trandolapril diketone in contrast, with the limit of control Trandolapril diketone.
Document is not seen the preparation report of this Trandolapril diketone.
Document (Journal of Medicinal Chemistry, 30 (6), 992-8; 1987) reported the preparation method of Trandolapril diketone optical isomer in:
(2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-and 1-(ethoxycarbonyl)-3-hydrocinnamyl] amino]-the 1-oxopropyl] octahydro-1H-Indoline-2-carboxylic acid (Trolapril optical isomer) is at I-hydroxybenzotriazole and DCC (N, N '-dicyclohexylcarbodiimide) effect down, room temperature reaction 24 hours, obtain ethyl-(2S)-2-[(3S, 5aS, 9aS, 10aS)-the 3-methyl isophthalic acid, 4-dioxo decahydro pyrazine is [1,2-a] indoles-2 (1H)-yl also]-4-phenylbutyric acid (Trandolapril diketone optical isomer).This method is used DCC, and it is more to produce the three wastes, and by product DCU of generation (N, N '-dicyclohexyl urea) and I-hydroxybenzotriazole all need reclaim, complex operation, yield only 47%.
Summary of the invention
For solving the technical problem that does not have well to prepare the method for Trandolapril diketone in the prior art, the present inventor utilizes the characteristics of Trolapril self, with it is raw material, organic solvent with the solubilized Trolapril is a solvent, react certain hour being less than or equal under the boiling temperature of this organic solvent, obtain Trandolapril diketone.
Therefore, the invention provides a kind of preparation method of Trandolapril diketone, comprise Trolapril is reacted in soluble organic solvent, wherein temperature of reaction is less than or equal to the boiling point of this organic solvent, promptly gets Trandolapril diketone.
Described organic solvent is toluene, benzene, methylene dichloride, chloroform or ethyl acetate, preferred toluene.
Temperature of reaction is preferably 70~110 ℃.
Reaction times is preferably 1~24 hour.
With respect to prior art, the advantage of the inventive method is as follows:
1. operation steps is simple;
2. yield is higher;
3. do not use DCC, reduce the three wastes, the protection environment.
Embodiment
Embodiment 1
(2S, 3aR, 7aS)-1-[(2S)-2-[[(1S)-and 1-(ethoxycarbonyl)-3-hydrocinnamyl] amino]-the 1-oxopropyl] octahydro-1H-Indoline-2-carboxylic acid (Trolapril) (10g, add toluene 20ml 23mmol), 110 ℃ of following backflow 7h, evaporated under reduced pressure gets white solid 9.1g, yield: 95%, and 142~144 ℃ of fusing points.MS(m/z):435(M+Na) +;847(2M+Na) +
Embodiment 2
(2S, 3aR, 7aS)-1-[(2S)-2-[[(1S)-and 1-(ethoxycarbonyl)-3-hydrocinnamyl] amino]-the 1-oxopropyl] octahydro-1H-Indoline-2-carboxylic acid (Trolapril) (1g, 2.3mmol) the middle ethyl acetate 20ml that adds, 77 ℃ are reacted 12h down, cross post and get white solid 0.69g, yield: 72%, 142~144 ℃ of fusing points.MS(m/z):435(M+Na) +;847(2M+Na) +
Embodiment 3
(2S, 3aR, 7aS)-1-[(2S)-2-[[(1S)-and 1-(ethoxycarbonyl)-3-hydrocinnamyl] amino]-the 1-oxopropyl] octahydro-1H-Indoline-2-carboxylic acid (Trolapril) (2g, 4.6mmol) the middle methylene dichloride 20ml that adds, 40 ℃ are reacted 22h down, cross post and get white solid 0.76g, yield: 40%, 142~144 ℃ of fusing points.MS(m/z):435(M+Na) +;847(2M+Na) +
Embodiment 4
(2S, 3aR, 7aS)-1-[(2S)-2-[[(1S)-and 1-(ethoxycarbonyl)-3-hydrocinnamyl] amino]-the 1-oxopropyl] octahydro-1H-Indoline-2-carboxylic acid (Trolapril) (2g, 4.6mmol) the middle benzene 20ml that adds, 80 ℃ of following backflow 10h, cross post and get white solid 1.5g, yield: 79%, 142~143 ℃ of fusing points.MS(m/z):435(M+Na) +;847(2M+Na) +
Embodiment 5
(2S, 3aR, 7aS)-1-[(2S)-2-[[(1S)-and 1-(ethoxycarbonyl)-3-hydrocinnamyl] amino]-the 1-oxopropyl] octahydro-1H-Indoline-2-carboxylic acid (Trolapril) (2g, 4.6mmol) the middle chloroform 20ml that adds, 61 ℃ are reacted 24h down, cross post and get white solid 1.1g, yield: 58%, 141~143 ℃ of fusing points.MS(m/z):435(M+Na) +;847(2M+Na) +
Embodiment 6
(2S, 3aR, 7aS)-1-[(2S)-2-[[(1S)-and 1-(ethoxycarbonyl)-3-hydrocinnamyl] amino]-the 1-oxopropyl] octahydro-1H-Indoline-2-carboxylic acid (Trolapril) (10g, add toluene 20ml 23mmol), 90 ℃ are reacted 20h down, evaporated under reduced pressure gets white solid 9.0g, yield: 94%, and 141~143 ℃ of fusing points.MS(m/z):435(M+Na) +;847(2M+Na) +
Embodiment 7
(2S, 3aR, 7aS)-1-[(2S)-2-[[(1S)-and 1-(ethoxycarbonyl)-3-hydrocinnamyl] amino]-the 1-oxopropyl] octahydro-1H-Indoline-2-carboxylic acid (Trolapril) (10g, add benzene 20ml 23mmol), 80 ℃ are reacted 20h down, evaporated under reduced pressure gets white solid 8.7g, yield: 91%, and 140~142 ℃ of fusing points.MS(m/z):435(M+Na) +;847(2M+Na) +

Claims (5)

1. the preparation method of Trandolapril diketone comprises Trolapril is reacted in soluble organic solvent, and wherein temperature of reaction is the boiling point of being less than or equal to this organic solvent, promptly gets Trandolapril diketone.
2. preparation method as claimed in claim 1, wherein said organic solvent is toluene, benzene, methylene dichloride, chloroform or ethyl acetate.
3. preparation method as claimed in claim 2, wherein said organic solvent is a toluene.
4. preparation method as claimed in claim 1, wherein said temperature of reaction are 70~110 ℃.
5. preparation method as claimed in claim 1, wherein the reaction times of this reaction is 1~24 hour.
CN2007100404217A 2007-05-08 2007-05-08 Preparation of Trandolapril diketone Expired - Fee Related CN101302218B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100404217A CN101302218B (en) 2007-05-08 2007-05-08 Preparation of Trandolapril diketone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100404217A CN101302218B (en) 2007-05-08 2007-05-08 Preparation of Trandolapril diketone

Publications (2)

Publication Number Publication Date
CN101302218A CN101302218A (en) 2008-11-12
CN101302218B true CN101302218B (en) 2011-02-23

Family

ID=40112333

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100404217A Expired - Fee Related CN101302218B (en) 2007-05-08 2007-05-08 Preparation of Trandolapril diketone

Country Status (1)

Country Link
CN (1) CN101302218B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933361A (en) * 1981-12-29 1990-06-12 Hoechst Aktiengesellschaft Derivatives of bicyclic aminoacids agents containing these compounds and their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933361A (en) * 1981-12-29 1990-06-12 Hoechst Aktiengesellschaft Derivatives of bicyclic aminoacids agents containing these compounds and their use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
C.J.Blankley J.S.Kaltenbronn
C.J.Blankley,J.S.Kaltenbronn,D.E.Dejohn er al..synthesis and structure-activity relationships of potent newangiotensin converting enzyme inhibitors containing saturatedbicycloic amino acids.J.MED.CHEM30.1987,30992-998. *

Also Published As

Publication number Publication date
CN101302218A (en) 2008-11-12

Similar Documents

Publication Publication Date Title
Liu et al. Simple organic molecules bearing a 3, 4-ethylenedioxythiophene linker for efficient dye-sensitized solar cells
ES2245621T1 (en) PROCESSES FOR AN ALCOHOLIC PRODUCT.
Villegas et al. Efficient light harvesting anionic heptamethine cyanine–[60] and [70] fullerene hybrids
WO2018188346A1 (en) Water and alcohol soluble triple bonded conjugated polymer and application thereof in organic optoelectronic device
Liu et al. Synthesis and photovoltaic performances of donor–π–acceptor dyes utilizing 1, 3, 5-triazine as π spacers
CN106478641A (en) The novel synthesis of Rui Boxini intermediate
Yang et al. Structure–property relationship of naphthalene based donor–π–acceptor organic dyes for dye-sensitized solar cells: remarkable improvement of open-circuit photovoltage
EP2161257A1 (en) Amorphous form of an L-arginine salt of perindopril and processes for preparation thereof
Matsui et al. Highly efficient substituted triple rhodanine indoline dyes in zinc oxide dye-sensitized solar cell
Chen et al. Metal-free indoline dye sensitized zinc oxide nanowires solar cell
Zheng et al. Designs of tandem catalysts and cascade catalytic systems for CO2 upgrading
CN101302218B (en) Preparation of Trandolapril diketone
CN103695494A (en) Method for integral preparation of products such as crocetin, genipin, gardenia blue and the like
CN103588862A (en) Synthesis and crystal form-transforming method of taltirelin
Çakıroğlu et al. Photosystem II as a chemiluminescence-induced photosensitizer for photoelectrochemical biofuel cell-type biosensing system
CN102617442A (en) Preparation method and use of 3,3'-methylenebis(1H-Indole)
CN105695551A (en) Biological method for preparing dehydroepiandrosterone
Ye et al. Enhanced photocurrent via π-bridge extension of perylenemonoimide-based dyes for p-Type dye-sensitized solar cells and photoelectrochemical Cells
CN103012268B (en) Novel preparation method for ivabradine
KR101728058B1 (en) Electrode unit comprising bio material and photoelectric connersion device comprising the same
KR101703569B1 (en) Hole transfer material, inorganic-organic hybrid solar cell using the same, and the manufacturing method thereof
JP2015089945A (en) Facilities for resource-recycling biotechnical hydrogen production from biomass
KR101473320B1 (en) Benzoindole-based compound and Dye sensitized solar cell using the same
WO2017117903A1 (en) Method for preparing 20(s)-protopanaxadiol
CN105862072A (en) Novel technical method for reducing nitrobenzene through zinc

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110223

Termination date: 20160508

CF01 Termination of patent right due to non-payment of annual fee